137 related articles for article (PubMed ID: 35338560)
1. Procarbazine, prednisolone and cyclophosphamide oral combination chemotherapy protocol for canine lymphoma.
O'Connell K; Thomson M; Morgan E; Henning J
Vet Comp Oncol; 2022 Sep; 20(3):613-622. PubMed ID: 35338560
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a multi-agent chemotherapy protocol combining lomustine, procarbazine and prednisolone (LPP) for the treatment of relapsed canine non-Hodgkin high-grade lymphomas.
Tanis JB; Mason SL; Maddox TW; Blackwood L; Killick DR; Amores-Fuster I; Harper A; Finotello R
Vet Comp Oncol; 2018 Sep; 16(3):361-369. PubMed ID: 29380942
[TBL] [Abstract][Full Text] [Related]
3. Canine T cell lymphoma treated with lomustine, vincristine, procarbazine, and prednisolone chemotherapy in 35 dogs.
Morgan E; O'Connell K; Thomson M; Griffin A
Vet Comp Oncol; 2018 Dec; 16(4):622-629. PubMed ID: 30117253
[TBL] [Abstract][Full Text] [Related]
4. Cyclophosphamide and prednisolone for chemotherapy naïve B cell multicentric lymphoma in dogs: 32 cases (2017-2021).
Todd J; Thomas P; Nguyen S
J Small Anim Pract; 2022 Jan; 63(1):52-55. PubMed ID: 34647324
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the University of Florida lomustine, vincristine, procarbazine, and prednisone chemotherapy protocol for the treatment of relapsed lymphoma in dogs: 33 cases (2003-2009).
Fahey CE; Milner RJ; Barabas K; Lurie D; Kow K; Parfitt S; Lyles S; Clemente M
J Am Vet Med Assoc; 2011 Jul; 239(2):209-15. PubMed ID: 21756176
[TBL] [Abstract][Full Text] [Related]
6. Comparison of efficacy and toxicity of doxorubicin and mitoxantrone in combination chemotherapy for canine lymphoma.
Wang SL; Lee JJ; Liao AT
Can Vet J; 2016 Mar; 57(3):271-6. PubMed ID: 26933263
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of mechlorethamine, vinblastine, procarbazine, and prednisone for the treatment of resistant multicentric canine lymphoma.
Zimmerman K; Walsh KA; Ferrari JT; Keuler NS; Atherton MJ; Lenz JA
Vet Comp Oncol; 2023 Sep; 21(3):503-508. PubMed ID: 37222086
[TBL] [Abstract][Full Text] [Related]
8. Assessment of temporal association of relapse of canine multicentric lymphoma with components of the CHOP protocol: Is cyclophosphamide the weakest link?
Wang SL; Lee JJ; Liao AT
Vet J; 2016 Jul; 213():87-9. PubMed ID: 27240922
[TBL] [Abstract][Full Text] [Related]
9. Prognostic indicators for naïve canine non-indolent T-cell lymphoma treated with combination lomustine, vincristine, procarbazine and prednisolone chemotherapy.
Blaxill J; Buzzacott P; Finlay J
Vet Comp Oncol; 2022 Mar; 20(1):215-226. PubMed ID: 34464024
[TBL] [Abstract][Full Text] [Related]
10. Prednisolone inclusion in a first-line multidrug cytostatic protocol for the treatment of canine lymphoma does not affect therapy results.
Zandvliet M; Rutteman GR; Teske E
Vet J; 2013 Sep; 197(3):656-61. PubMed ID: 23746872
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).
Valerius KD; Ogilvie GK; Mallinckrodt CH; Getzy DM
J Am Vet Med Assoc; 1997 Feb; 210(4):512-6. PubMed ID: 9040837
[TBL] [Abstract][Full Text] [Related]
12. Treatment of dogs with lymphoma using a 12-week, maintenance-free combination chemotherapy protocol.
Simon D; Nolte I; Eberle N; Abbrederis N; Killich M; Hirschberger J
J Vet Intern Med; 2006; 20(4):948-54. PubMed ID: 16955821
[TBL] [Abstract][Full Text] [Related]
13. MOPP chemotherapy for treatment of resistant lymphoma in dogs: a retrospective study of 117 cases (1989-2000).
Rassnick KM; Mauldin GE; Al-Sarraf R; Mauldin GN; Moore AS; Mooney SC
J Vet Intern Med; 2002; 16(5):576-80. PubMed ID: 12322709
[TBL] [Abstract][Full Text] [Related]
14. Comparison of combination l-asparaginase plus CHOP or modified MOPP treatment protocols in dogs with multi-centric T-cell or hypercalcaemic lymphoma.
Angelo G; Cronin K; Keys D
J Small Anim Pract; 2019 Jul; 60(7):430-437. PubMed ID: 30790291
[TBL] [Abstract][Full Text] [Related]
15. Gastrointestinal and hematologic adverse events after administration of vincristine, cyclophosphamide, and doxorubicin in dogs with lymphoma that underwent a combination multidrug chemotherapy protocol.
Tomiyasu H; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
J Vet Med Sci; 2010 Nov; 72(11):1391-7. PubMed ID: 20543531
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of a 15-week CHOP protocol for the treatment of canine multicentric lymphoma.
Burton JH; Garrett-Mayer E; Thamm DH
Vet Comp Oncol; 2013 Dec; 11(4):306-15. PubMed ID: 22548975
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a multidrug chemotherapy protocol with mitoxantrone based maintenance (CHOP-MA) for the treatment of canine lymphoma.
Daters AT; Mauldin GE; Mauldin GN; Brodsky EM; Post GS
Vet Comp Oncol; 2010 Mar; 8(1):11-22. PubMed ID: 20230577
[TBL] [Abstract][Full Text] [Related]
18. Thirteen-week dose-intensifying simultaneous combination chemotherapy protocol for malignant lymphoma in dogs.
Zenker I; Meichner K; Steinle K; Kessler M; Hirschberger J
Vet Rec; 2010 Nov; 167(19):744-8. PubMed ID: 21257510
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of combination chemotherapy for treatment of gastrointestinal lymphoma in dogs.
Rassnick KM; Moore AS; Collister KE; Northrup NC; Kristal O; Chretin JD; Bailey DB
J Vet Intern Med; 2009; 23(2):317-22. PubMed ID: 19192147
[TBL] [Abstract][Full Text] [Related]
20. LOPP chemotherapy as a first-line treatment for dogs with T-cell lymphoma.
Brown PM; Tzannes S; Nguyen S; White J; Langova V
Vet Comp Oncol; 2018 Mar; 16(1):108-113. PubMed ID: 28508557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
